Related Experiment Video

Updated: May 26, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Study on the autophagy of prostate cancer PC-3 cells induced by oridonin

Li-Hong Ye1, Wang-Jian Li, Xiao-Qiang Jiang

  • 1Department of Urology Surgery, Shaoxing County Central Hospital, Shaoxing 312030, China. ylh7966@126.com

Anatomical Record (Hoboken, N.J. : 2007)
|December 23, 2011
PubMed

Insights

Oridonin (ORI) inhibits prostate cancer cell growth by inducing autophagy. This process involves increased autophagosomes and key protein expression, suggesting ORI

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • Prostate cancer remains a significant health concern, necessitating novel therapeutic strategies.
  • Autophagy, a cellular degradation process, plays a complex role in cancer development and treatment.
  • Oridonin (ORI), a natural compound, has shown potential cytotoxic effects against cancer cells.

Purpose of the Study:

  • To elucidate the mechanism by which oridonin (ORI) induces autophagy in prostate cancer PC-3 cells.
  • To investigate the impact of ORI on cell proliferation, ultrastructure, and autophagy-related markers in PC-3 cells.

Main Methods:

  • Cell viability was assessed using the MTT assay.
  • Ultrastructural changes were observed via light microscopy, scanning electron microscopy (SEM), and transmission electron microscopy (TEM).
  • Autophagy was evaluated through acridine orange (AO) staining for acidic vesicular organelles (AVOs), Western blot for MAP1-LC3, and RT-PCR for beclin 1 mRNA.

Main Results:

  • ORI significantly inhibited PC-3 cell proliferation in a dose- and time-dependent manner.
  • SEM and TEM revealed cellular shrinkage, microvilli loss, chromatin condensation, and increased autophagosomes.
  • ORI treatment upregulated LC3 expression and beclin 1 mRNA levels, which were reversed by the autophagy inhibitor 3-methyladenine.

Conclusions:

  • Oridonin (ORI) effectively inhibits prostate cancer PC-3 cell growth.
  • ORI induces autophagy in PC-3 cells, characterized by morphological changes and altered expression of autophagy markers.
  • ORI demonstrates potential as an antitumor agent for prostate cancer through autophagy induction.

More Related Videos

Study of Protein-protein Interactions in Autophagy Research14:08

Study of Protein-protein Interactions in Autophagy Research

Published on: September 9, 2017

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...